Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FZ1AG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $276,402
Award facts
- Contract value 100% obligated
- $276,401.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on September 16, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $276,401.53 in firm fixed price funding for the supply of Dupixent 300 mg/2 mL pen injectors. The order is scheduled for ultimate completion by September 17, 2025, and represents a competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. The IDC encompasses specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. Dupixent is a biologic immunosuppressant commonly used to treat eczema, asthma, and other allergic inflammatory conditions, making this order consistent with DLA's role in supplying essential medications to the federal healthcare ecosystem.
Quick answers
Who was awarded contract SPE2DB25FZ1AG?
SPE2DB25FZ1AG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FZ1AG worth?
The government has obligated $276,402 on SPE2DB25FZ1AG.
Is contract SPE2DB25FZ1AG an order under another contract?
Yes. SPE2DB25FZ1AG is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ1AG competed?
The extent of competition for SPE2DB25FZ1AG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award